Once the Covid-19 emergency order is lifted, new restrictions proposed by the White House will make it harder for many to access the medications on which they depend.

Yes, Build Back Better eventually became Build Back Manchin, but for Democrats, it’s better than nothing.

Lawmakers are touting a proposed cap on prices, but the benefit won’t swing to the patients with the most desperate needs.

The congressman leading the fight to kill his party’s prescription drug proposal has been taking checks from pharmaceutical interests this whole time.

The Arizona senator wants to cut funding for climate-change policies and opposes a plan to rein in prescription drug prices. She doesn’t deserve the Democratic Party.

The industry’s titanic profits power a perpetual stranglehold over our government with only one goal in mind: raking you clean of every last dime.

Thanks to one judge, members of the family that made billions from OxyContin could escape justice for their role in the opioid epidemic. Mike Quinn may be the best hope of holding them to account.

After a nine month effort to produce a bill that Trump might support, it looks like Nancy Pelosi outfoxed herself.

The controversial proposed deal with Purdue Pharma hints at better alternatives to for-profit pharmaceutical companies.

Or are they just looking to cut a deal for the sake of cutting a deal?

The House of Representatives' first oversight hearing of 2019 wasn't about Trump. It was about skyrocketing drug prices.

A bold solution to America's soaring drug prices